Oil’s Iran Cliffhanger: What To Know And What To Expect
- Analysis
- Barani Krishnan
- 3
Name | Last | Prev. | High | Low | Chg. % | Vol. | Time | Price | |
---|---|---|---|---|---|---|---|---|---|
MSB Mesoblast Ltd | 3.02 | 3.02 | 3.26 | 2.95 | -5.33% | 11.8M | 3.02-5.33% | 05/02 | |
OPT Opthea Ltd | 1.10 | 1.10 | 1.11 | 1.07 | +1.85% | 4.18M | 1.10+1.85% | 05/02 | |
PAR Paradigm Biopharmaceuticals Ltd | 0.55 | 0.55 | 0.56 | 0.54 | -1.80% | 1.91M | 0.55-1.80% | 05/02 | |
TLX Telix Pharmaceuticals Ltd | 29.15 | 29.15 | 29.65 | 28.79 | -1.45% | 1.25M | 29.15-1.45% | 05/02 | |
CSL CSL Ltd | 270.34 | 270.34 | 275.70 | 268.88 | -1.17% | 877.23K | 270.34-1.17% | 05/02 |
Name | Price |
---|---|
AVH Avita Therapeutics | 2.95+0.080+2.79% |
MYX Mayne Pharma | 4.60+0.100+2.22% |
OPT Opthea | 1.10+0.02+1.85% |
CUV Clinuvel Pharmaceuticals | 11.56+0.01+0.09% |
SPL Starpharma Holdings | 0.100.000.00% |
Name | Price |
---|---|
MVP Medical Developments | 0.66-0.075-10.88% |
MSB Mesoblast | 3.02-0.170-5.33% |
PAR Paradigm Biopharmaceuticals Ltd | 0.55-0.01-1.80% |
TLX Telix Pharma | 29.15-0.430-1.45% |
CSL CSL | 270.34-3.20-1.17% |